A microbiome-bile acid axis mediates protection from chronic liver disease in females.

IsoUDCA, a bile acid linked to a bacterial consortium enriched by estrogen, may mediate female hepatoprotection in chronic liver disease.

• Why it matters: Understanding sex differences in CLD incidence and progression is crucial, as the mechanisms behind this disparity are not well understood, limiting targeted therapies.
• What they did: Researchers analyzed a metabolomics database of 9,254 individuals and identified isoUDCA as a candidate mediator, tracing its origin to bacteria influenced by estrogen and examining its effects on liver cells.
• The result: Findings suggest a microbiome-bile acid-liver axis involving isoUDCA that could explain sex differences in CLD susceptibility and highlight its potential as a therapeutic target.